Beamer N, Coull B M, Sexton G, de Garmo P, Knox R, Seaman G
Oregon Health Sciences University, Portland.
Stroke. 1993 Aug;24(8):1133-9. doi: 10.1161/01.str.24.8.1133.
In following patients initially recruited for a cross-sectional study of blood viscosity in ischemic cerebrovascular disease, it was noted that those having a low albumin-globulin ratio appeared to experience the majority of subsequent vascular events. Accordingly, a prospective study in which subjects were assigned to a high or low albumin-globulin cohort was undertaken to examine the relation between a low albumin-globulin ratio, the presence of clinical risk factors for stroke, and the occurrence of subsequent stroke, myocardial infarction, or vascular death.
Three groups of subjects were followed for an average of 1.5 +/- 0.8 years to ascertain vascular end points. Group 1 consisted of 126 patients with acute ischemic stroke; group 2 included 109 subjects matched with group 1 for age, medications, and recognized clinical risk factors for stroke; and group 3 was composed of 84 healthy volunteers, matched for age with groups 1 and 2. The median albumin-globulin ratio for group 1 at enrollment, 1.45, was used to dichotomize patients into two cohorts: all subjects with an albumin-globulin ratio of 1.45 or less were assigned to the "low" albumin-globulin cohort; those whose ratio was greater than 1.45 were assigned to the "high" albumin-globulin cohort. The occurrence of vascular end points was verified during subsequent hospitalizations and outpatient clinic visits and by telephone interviews of patients and providers.
A total of 51 vascular events occurred, including 39 in group 1, 8 in group 2, and 4 in group 3. Subjects in either group 1 or 2 who were in the low albumin-globulin cohort had at least double the risk for a subsequent vascular event compared with their counterparts in the high albumin-globulin cohort (P < .01 and P < .03, respectively). In comparison with the high albumin-globulin cohort, significantly more patients in the low albumin-globulin cohort in group 1 had a history of prior stroke (P < .03). When groups 1 and 2 were combined, both a low albumin-globulin ratio and diabetes had a significant independent association with increased risk for subsequent vascular events in a Cox proportional-hazards model (P < .01 and P < .03, respectively).
The results of this study indicate that significantly increased risk for subsequent vascular events in stroke patients and in subjects with clinical risk factors for stroke is associated with a shift in the concentrations of blood proteins to a prothrombotic environment characterized by lower levels of albumin and an increased concentration of globulins and fibrinogen.
在对最初招募的缺血性脑血管疾病患者进行血液粘度横断面研究时,发现白蛋白 - 球蛋白比率低的患者似乎经历了大多数后续血管事件。因此,开展了一项前瞻性研究,将受试者分为高或低白蛋白 - 球蛋白队列,以研究低白蛋白 - 球蛋白比率、中风临床危险因素的存在与随后中风、心肌梗死或血管性死亡发生之间的关系。
对三组受试者平均随访1.5±0.8年以确定血管终点。第1组由126例急性缺血性中风患者组成;第2组包括109名在年龄、用药情况和公认的中风临床危险因素方面与第1组匹配的受试者;第3组由84名健康志愿者组成,年龄与第1组和第2组匹配。第1组入组时白蛋白 - 球蛋白比率的中位数为1.45,据此将患者分为两个队列:白蛋白 - 球蛋白比率为1.45或更低的所有受试者被分配到“低”白蛋白 - 球蛋白队列;比率大于1.45的受试者被分配到“高”白蛋白 - 球蛋白队列。在随后的住院治疗、门诊就诊以及通过对患者和医护人员的电话访谈来核实血管终点的发生情况。
共发生51例血管事件,其中第1组39例,第2组8例,第3组4例。第1组或第2组中处于低白蛋白 - 球蛋白队列的受试者发生后续血管事件的风险至少是其高白蛋白 - 球蛋白队列对应者的两倍(分别为P <.01和P <.03)。与高白蛋白 - 球蛋白队列相比,第1组低白蛋白 - 球蛋白队列中有更多患者有既往中风史(P <.03)。当将第1组和第2组合并时,在Cox比例风险模型中,低白蛋白 - 球蛋白比率和糖尿病均与后续血管事件风险增加有显著独立关联(分别为P <.01和P <.03)。
本研究结果表明,中风患者及有中风临床危险因素的受试者发生后续血管事件的风险显著增加,这与血液蛋白质浓度向以白蛋白水平降低、球蛋白和纤维蛋白原浓度增加为特征的促血栓形成环境转变有关。